Abstract:Overdose of acetaminophen (APAP), the most widely used analgesic, results in acute liver failure. We have investigated the role of a post‐translational modification of proteins called O‐GlcNAcylation in pathogenesis of APAP‐induced liver injury, where a single β‐D‐N‐acetylglucosamine (O‐GlcNAc) moiety is added to proteins by an enzyme called O‐GlcNAc transferase (OGT) and removed by an enzyme called O‐GlcNAcase (OGA). Male C57BL/6J mice were treated with 300 mg/kg APAP followed by Thiamet‐G (TMG, 400 mg/kg) a specific inhibitor of OGA that induces O‐GlcNAcylation, 1.5 hr after APAP administration. Progression of liver injury was studied over a time course of 0 to 24 hr. TMG treatment resulted in significant increase in hepatic O‐GlcNAc. The mice treated with 400 mg/kg TMG exhibited significantly higher APAP‐induced liver injury as indicated by increase in serum transaminase levels and histopathological analysis, as well as a prolonged JNK activation. Treatment with TMG did not affect hepatic CYP2E1 levels, APAP protein adduct formation, APAP induced mitochondrial damage, hepatic glutathione (GSH), or depletion of GSH after APAP treatment. C57BL/6J mice were also treated with 50 mg/kg TMG every other day for 15 days followed by 300 mg/kg APAP and sacrificed at 24 hr. Mice treated with 50 mg/kg TMG showed a similar increase in APAP‐induced liver injury. Next we used hepatocyte specific OGT knockout mice (OGT KO), which have decreased O‐GlcNAcylation to study APAP toxicity. OGT KO and WT control mice were treated with 300 mg/kg and sacrificed on a timecourse from 0–24 hr. OGT KO mice showed dramatic decrease in liver injury as compared to WT mice. APAP protein adducts was significantly decreased in OGT KO mice when compared to WT control mice. There was no difference CYP2E1 activity showing that OGT KO did not alter cytochrome P450 levels and alter APAP metabolism. Hepatic GSH depletion was equal in OGT KO and WT mice but GSH was rapidly replenished by 6hr after APAP treatment in OGT KO mice, while WT mice did not fully replenish until 24hr post APAP. Taken together, these data indicate that induction in cellular O‐GlcNAcylation exacerbates and decrease in O‐GlcNAcylation protects from APAP induced liver injury. These studies have identified a novel mechanism of pathogenesis of acute liver injury induced by APAP and highlighted a novel therapeutic target for acute liver failure. Support or Funding Information R01DK098414

Deletion of Glyoxalase 1 Exacerbates Acetaminophen-Induced Hepatotoxicity in Mice

Role of Hepatic O‐GlcNAcylation on Acetaminophen‐Induced Liver Injury

Glutaredoxin-1 Alleviates Acetaminophen-Induced Liver Injury by Decreasing Its Toxic Metabolites

EGR1 is Crucial for the Chlorogenic Acid–provided Promotion on Liver Regeneration and Repair after APAP-induced Liver Injury

Glycyrrhizin Protects Against Acetaminophen-Induced Acute Liver Injury Via Alleviating Tumor Necrosis Factor Alpha-Mediated Apoptosis

Activation of P62-Keap1-nrf2 Antioxidant Pathway in the Early Stage of Acetaminophen-Induced Acute Liver Injury in Mice

In vivo upstream factors of mouse hepatotoxic mechanism with sustained hepatic glutathione depletion: Acetaminophen metabolite-erythrocyte adducts and splenic macrophage-generated reactive oxygen species

Post-treatment with Glycyrrhizin Can Attenuate Hepatic Mitochondrial Damage Induced by Acetaminophen in Mice

GLT25D2 is Critical for Inflammatory Immune Response to Promote Acetaminophen-Induced Hepatotoxicity by Autophagy Pathway

Inhibiting Hepatocyte Uric Acid Synthesis and Reabsorption Ameliorates Acetaminophen-Induced Acute Liver Injury in Mice.

Suppression of glomerular damage and apoptosis and biomarkers of acute kidney injury induced by acetaminophen toxicity using a combination of resveratrol and quercetin

JNK Signaling Pathway Mediates Acetaminophen-Induced Hepatotoxicity Accompanied by Changes of Glutathione S-Transferase A1 Content and Expression

Hyperglycemia exacerbates acetaminophen-induced acute liver injury by promoting liver-resident macrophage proinflammatory response via AMPK/PI3K/AKT-mediated oxidative stress

Dynamic and coordinated regulation of KEAP1-NRF2-ARE and p53/p21 signaling pathways is associated with acetaminophen injury responsive liver regeneration.

The concerted elevation of conjugation reactions is associated with the aggravation of acetaminophen toxicity in Akr1a-knockout mice with an ascorbate insufficiency

Ganoderma lucidum Polysaccharides Ameliorate Acetaminophen-Induced Acute Liver Injury by Inhibiting Oxidative Stress and Apoptosis along the Nrf2 Pathway

Rosiglitazone Protects against Acetaminophen-Induced Acute Liver Injury by Inhibiting Multiple Endoplasmic Reticulum Stress Pathways

Glycyrrhetinic Acid Prevents Acetaminophen-Induced Acute Liver Injury Via the Inhibition of CYP2E1 Expression and HMGB1-TLR4 Signal Activation in Mice.

The TGFβ1 Receptor Antagonist GW788388 Reduces JNK Activation and Protects Against Acetaminophen Hepatotoxicity in Mice

N-Acetyl Cysteine Overdose Inducing Hepatic Steatosis and Systemic Inflammation in Both Propacetamol-Induced Hepatotoxic and Normal Mice

Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy